Total planned funding: $207,575,551
Allocations
Countries/Regions
India | $207,575,551 |
Organizational Types
Unknown | $104,849,687 |
NGO | $53,923,511 |
Own Agency | $26,809,045 |
University | $10,700,000 |
Multi-lateral Agency | $3,466,808 |
Implementing Agency | $3,100,000 |
FBO | $1,800,000 |
Private Contractor | $1,509,000 |
Host Country Government Agency | $1,010,200 |
Other USG Agency | $407,300 |
Program Areas
Governance and Systems | $80,726,008 |
Prevention | $51,941,639 |
Care | $27,568,843 |
Management and Operations | $20,693,143 |
Testing | $12,214,985 |
Treatment | $10,003,141 |
Budget Codes
OHSS: Health Systems Strengthening | $45,129,697 |
HVSI: Strategic Information | $27,291,930 |
HVOP: Sexual Prevention: Other Sexual Prevention | $26,746,262 |
HVMS: Management and Operations | $20,693,143 |
HBHC: Care: Adult Care and Support | $18,502,195 |
HVCT: Testing: HIV Testing and Counseling | $12,214,985 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $11,607,508 |
HTXS: Treatment: Adult Treatment | $9,499,927 |
HLAB: Laboratory Infrastructure | $8,304,381 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $7,228,144 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,270,718 |
HKID: Care: Orphans and Vulnerable Children | $4,805,273 |
HVTB: Care: TB/HIV | $3,786,613 |
HMBL: Biomedical Prevention: Blood Safety | $1,089,007 |
PDTX: Treatment: Pediatric Treatment | $503,214 |
PDCS: Care: Pediatric Care and Support | $474,762 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$103,802,198
Countries/Regions
USG Aggregated Agencies:
$23,429,929
Countries/Regions
FHI 360:
$23,138,228
Countries/Regions
Voluntary Health Services:
$7,780,000
Countries/Regions